Analyst firms · Berenberg · MRK

Berenberg MRK price target and rating history

Merck & Company Inc. (MRK) · Health Care

Berenberg rates Merck & Company Inc. (MRK) Hold with a $90 price target, as of its latest action on Sep 17, 2025. It has published 3 rating actions on MRK since October 2021, including 1 upgrade and 1 downgrade. Across 10 firms with a MRK price target in the last 12 months, the median target is $141.50.

Current rating
Hold
Price target
$90
Median target, all firms
$141.50
Actions on MRK
3

Berenberg price target on MRK

$100$95$9020222023202420252026
Berenberg price target on MRK, each point a stated target, October 2021 to September 2025.

Every Berenberg rating on MRK

How other firms rate MRK

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
DZ BankHold$153Nov 3, 2026
RBC Capital MarketsSector Perform$150Aug 20, 2026
Morgan StanleyOverweight$179Aug 20, 2026
DaiwaOutperform$143Aug 12, 2026
CitigroupNeutral$125May 6, 2026
BarclaysOverweight$140Feb 20, 2026
Deutsche BankBuy$150Feb 13, 2026
Wolfe ResearchOutperform$135Jan 8, 2026
BMO Capital MarketsOutperform$130Dec 18, 2025
Wells FargoOverweight$125Nov 24, 2025

Questions about Berenberg and MRK

What is Berenberg's price target for MRK?
Berenberg's latest stated price target for Merck & Company Inc. (MRK) is $90, from its action on Sep 17, 2025.
What is Berenberg's rating on MRK?
Berenberg rates MRK Hold, a neutral rating, as of Sep 17, 2025.
When did Berenberg last change its view on MRK?
On Sep 17, 2025, Berenberg downgrades to Hold from Buy, price target $90.
How does Berenberg's MRK target compare with other analysts?
Across 10 firms with a MRK price target in the last 12 months, the median target is $141.50.

More MRK rating histories

All Berenberg ratingsMRK news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.